Aktieanalys

ChromoGenics: Robust order intake signals potential sales growth next year - Redeye

{newsItem.title}

Redeye Publicerad: 01 Dec 2023 08:44

Redeye provides an update on ChromoGenics following the company's Q3 2023 results. New cooperations with strong order intatake signalls a potential turnaround. We estimate sales to double next year.

Länk till analysen i sin helhet: https://www.redeye.se/research/945115/chromogenics-robust-order-intake-signals-potential-sales-growth-next-year?utm_source=finwire&utm_medium=RSS

Nyheter om ChromoGenics

Läses av andra just nu

Om aktien ChromoGenics

Senaste nytt